The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Perspectives

Balancing the expansion of transcatheter interventions for heart valve disease

EuroIntervention 2020;15:e1567-e1569. DOI: 10.4244/EIJV15I18A287



The field of transcatheter repair and replacement procedures has grown exponentially in the last decade, dramatically changing the evaluation and management of patients with valvular heart disease (VHD). Transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of patients affected by symptomatic severe aortic stenosis with higher operative risk. In 2019, based on two recent dedicated randomised trials, TAVI also obtained regulatory approval for lower-risk populations, thus widening the pool of patients eligible to this less invasive treatment1. Transcatheter repair of mitral regurgitation (MR) with the edge-to-edge MitraClip® device (Abbott Vascular, Santa Clara, CA, USA) has recently achieved an ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes